Search research articles
Contact Us
Filters
Showing results (1001-1010 of 1,025) with videos related to
Page
of 103
Sort By:
Plos Neglected Tropical Diseases
|
June 1, 2026
Performance of fecal inflammatory biomarkers to identify watery shigellosis: Findings from the Enterics for Global Health (EFGH) Shigella surveillance study
Billy Ogwel, Farhana Khanam, Henry Badji, et al.
Cancer Discovery
|
February 22, 2019
Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases
Grant M Fischer, Ali Jalali, David A Kircher, et al.
The Lancet. Oncology
|
January 24, 2018
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial
Rodabe N Amaria, Peter A Prieto, Michael T Tetzlaff, et al.
Nature Medicine
|
March 30, 2023
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results
Isabella C Glitza Oliva, Sherise D Ferguson, Roland Bassett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2018
Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations
Curtis H Kugel, Stephen M Douglass, Marie R Webster, et al.
Nature
|
October 26, 2022
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Rodabe N Amaria, Michael Postow, Elizabeth M Burton, et al.
Cancer Discovery
|
December 10, 2015
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
Weiyi Peng, Jie Qing Chen, Chengwen Liu, et al.
The Lancet. Oncology
|
February 17, 2018
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
Jennifer L McQuade, Carrie R Daniel, Kenneth R Hess, et al.
The Journal of Infectious Diseases
|
July 5, 2023
Azithromycin for Bacterial Watery Diarrhea: A Reanalysis of the AntiBiotics for Children With Severe Diarrhea (ABCD) Trial Incorporating Molecular Diagnostics
Patricia B Pavlinac, James A Platts-Mills, Jie Liu, et al.
Eclinicalmedicine
|
July 1, 2026
The consequences of <i>Shigella</i> medically-attended diarrhoea and other leading pathogens among young children living in high-burden settings: a multi-country prospective cohort study
Donnie Mategula, Bakary Conteh, Christine J McGrath, et al.
Page
of 103
Search research articles
Search
Showing results (1001-1010 of 1,025) with videos related to
Sort By:
Page
of 103
Plos Neglected Tropical Diseases
|
June 1, 2026
Performance of fecal inflammatory biomarkers to identify watery shigellosis: Findings from the Enterics for Global Health (EFGH) Shigella surveillance study
Billy Ogwel, Farhana Khanam, Henry Badji, et al.
Cancer Discovery
|
February 22, 2019
Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases
Grant M Fischer, Ali Jalali, David A Kircher, et al.
The Lancet. Oncology
|
January 24, 2018
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial
Rodabe N Amaria, Peter A Prieto, Michael T Tetzlaff, et al.
Nature Medicine
|
March 30, 2023
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results
Isabella C Glitza Oliva, Sherise D Ferguson, Roland Bassett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2018
Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations
Curtis H Kugel, Stephen M Douglass, Marie R Webster, et al.
Nature
|
October 26, 2022
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Rodabe N Amaria, Michael Postow, Elizabeth M Burton, et al.
Cancer Discovery
|
December 10, 2015
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
Weiyi Peng, Jie Qing Chen, Chengwen Liu, et al.
The Lancet. Oncology
|
February 17, 2018
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
Jennifer L McQuade, Carrie R Daniel, Kenneth R Hess, et al.
The Journal of Infectious Diseases
|
July 5, 2023
Azithromycin for Bacterial Watery Diarrhea: A Reanalysis of the AntiBiotics for Children With Severe Diarrhea (ABCD) Trial Incorporating Molecular Diagnostics
Patricia B Pavlinac, James A Platts-Mills, Jie Liu, et al.
Eclinicalmedicine
|
July 1, 2026
The consequences of <i>Shigella</i> medically-attended diarrhoea and other leading pathogens among young children living in high-burden settings: a multi-country prospective cohort study
Donnie Mategula, Bakary Conteh, Christine J McGrath, et al.
Page
of 103